8-K: Safety Shot Urges Shareholder Proxy Votes Ahead of Key Annual Meeting Addressing Strategic Proposals

Safety Shot, Inc. reminds shareholders to vote their proxy for the upcoming Annual Shareholders Meeting on June 12, 2025, where critical proposals including share issuances, an equity incentive plan amendment, and a potential reverse stock split will be considered.

Summary

• Safety Shot, Inc. (Nasdaq: SHOT) issued a press release on May 29, 2025, reminding shareholders about its Annual Shareholders Meeting.
• The virtual-only meeting is scheduled for Thursday, June 12, 2025, at 11:00 AM EDT, requiring advance registration at www.virtualshareholdermeeting.com/SHOT2025SM.
• Shareholders of record as of April 28, 2025, are entitled to vote.
• Key proxy proposals include approving share issuances for Yerba Shareholders, amending the 2024 equity incentive plan to increase reserved shares, and authorizing the issuance of promissory notes and underlying shares from a January 20, 2025 offering.
• Shareholders will also vote on the issuance of up to 20,000,000 shares to Core 4 Capital Corp. in non-public offerings to comply with Nasdaq listing rules.
• A significant proposal is to grant authority to the Board of Directors for a reverse stock split at a ratio between 1-for-5 and 1-for-35, to be effected within one year of approval.
• An adjournment proposal is also on the agenda, allowing the meeting to be postponed if necessary to solicit additional proxies or establish a quorum.
• Safety Shot is a wellness and dietary supplement company known for its product 'Sure Shot,' which is designed to lower blood alcohol content and improve mood, clarity, and energy.
• Sure Shot is currently available online via sureshot.com, walmart.com, and Amazon, with business-to-business sales to distributors, retailers, restaurants, and bars planned throughout 2025.

Sentiment

Score: 4

Explanation: The sentiment is mixed to slightly negative. While the company is actively pursuing strategic initiatives and expanding its product distribution, the proposals for a significant reverse stock split and multiple share issuances, particularly those related to past settlements and Nasdaq compliance, suggest underlying financial or market challenges that could dilute existing shareholders and negatively impact stock perception.

Positives

• The company is actively engaging with shareholders through an Annual Meeting to seek approval for strategic corporate actions.
• Proposals for share issuance related to the Yerba Arrangement Agreement and an equity incentive plan suggest ongoing business development and employee motivation.
• The company's product, 'Sure Shot,' is available through major online retailers (Walmart.com, Amazon) and its own website, indicating market presence.
• Safety Shot plans to expand its business-to-business sales of 'Sure Shot' to distributors, retailers, restaurants, and bars throughout 2025, indicating growth initiatives.

Negatives

• The proposal for a reverse stock split (1-for-5 to 1-for-35) often indicates a low stock price and a need to maintain Nasdaq listing compliance, which can be perceived negatively by investors.
• Multiple proposals for share issuances (Yerba, incentive plan, settlement notes, Core 4 Capital Corp.) suggest potential significant dilution for existing shareholders.
• The issuance of promissory notes and underlying shares from a January 20, 2025 offering, requiring shareholder approval for Nasdaq compliance, could indicate past financial challenges or complex financing structures.

Risks

• Shareholder dilution risk from the proposed issuance of shares to Yerba Shareholders, for the equity incentive plan, for the settlement of promissory notes, and up to 20,000,000 shares to Core 4 Capital Corp.
• Potential negative market perception and further stock price decline if the proposed reverse stock split is implemented, despite its aim to maintain Nasdaq listing.
• Risk of not obtaining sufficient shareholder votes for critical proposals, which could impede strategic initiatives or Nasdaq compliance.
• Operational risks associated with the planned expansion of business-to-business sales for 'Sure Shot' in 2025.

Future Outlook

Safety Shot plans to introduce business-to-business sales of its 'Sure Shot' product to distributors, retailers, restaurants, and bars throughout 2025, indicating a strategic focus on expanding market reach beyond direct-to-consumer channels.

Management Comments

• Safety Shot urges shareholders to submit their vote promptly via the internet, telephone, or mail, whether or not they plan to attend the Annual Meeting, emphasizing the importance of their vote.

Industry Context

Safety Shot operates within the wellness and dietary supplement industry, a growing market driven by consumer interest in health and well-being. Its product, 'Sure Shot,' targets a specific niche related to alcohol metabolism and recovery, differentiating it from general wellness products. The planned expansion into B2B sales aligns with broader industry trends of seeking diverse distribution channels.

Corporate Governance

Related Party Transactions

• Issuance of Safety Shot Shares to Yerba Shareholders in connection with the Arrangement Agreement.
• Issuance of up to 20,000,000 Safety Shot Shares to Core 4 Capital Corp. in one or more non-public offerings.

Stakeholder Impact

• Shareholders: Potential for significant dilution from various share issuance proposals; impact on stock price and perception from a potential reverse stock split; direct involvement through voting on critical corporate actions.
• Employees: Benefit from an increased pool of shares for the equity incentive plan, potentially enhancing compensation and retention.
• Core 4 Capital Corp.: Will become a significant shareholder if the proposal to issue up to 20,000,000 shares is approved and executed.
• Yerba Shareholders: Will receive Safety Shot Shares as part of an Arrangement Agreement.

Next Steps

• Shareholders are urged to vote their proxy for the Annual Shareholders Meeting on June 12, 2025.
• The Annual Meeting will address and vote on key proposals including share issuances, an equity incentive plan amendment, and a potential reverse stock split.
• The Board of Directors will determine the exact ratio for the reverse stock split, if approved, within one year of the proposal's approval.
• Safety Shot plans to expand business-to-business sales of 'Sure Shot' throughout 2025.

Key Dates

Keywords

Safety Shot, SHOT, Annual Meeting, Proxy, Shareholder Vote, Reverse Stock Split, Share Issuance, Nasdaq Listing, Equity Incentive Plan, Wellness Supplement, Dietary Supplement, Sure Shot, Corporate Governance